Inhibition of lysosomal functions reduces proteasomal activity

Neuroscience Letters

Volumn 456, Issue 1, 2009, Pages 15-19

  Qiao, Liyan ^a   Zhang, Jianhua ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

Lysosomes; Proteasomes; Ubiquitin

Indexed keywords

CELL PROTEIN; CHAPERONE; HEAT SHOCK COGNATE PROTEIN 70; LYSOSOME ENZYME; PROTEASOME;

ARTICLE; AUTOPHAGY; CONTROLLED STUDY; DEGENERATIVE DISEASE; HOMEOSTASIS; HUMAN; HUMAN CELL; INHIBITION KINETICS; LYSOSOME; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UPREGULATION;

ACETYLCYSTEINE; ALPHA-SYNUCLEIN; AMMONIUM CHLORIDE; AUTOPHAGY; BLOTTING, WESTERN; CELL LINE, TUMOR; CHLOROQUINE; ENZYME INHIBITORS; HSC70 HEAT-SHOCK PROTEINS; HSP90 HEAT-SHOCK PROTEINS; HUMANS; HYDROGEN-ION CONCENTRATION; LYSOSOMES; NEURONS; PROTEASOME ENDOPEPTIDASE COMPLEX;

EID: 64749103447     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.03.085     Document Type: Article

References (66)

1. Anderson C., Crimmins S., Wilson J.A., Korbel G.A., Ploegh H.L., and Wilson S.M. Loss of Usp14 results in reduced levels of ubiquitin in ataxia mice. J. Neurochem. 95 (2005) 724-731
2. Anglade P., Vyas S., Javoy-Agid F., Herrero M.T., Michel P.P., Marquez J., Mouatt-Prigent A., Ruberg M., Hirsch E.C., and Agid Y. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol. Histopathol. 12 (1997) 25-31
3. Bandhyopadhyay U., and Cuervo A.M. Chaperone-mediated autophagy in aging and neurodegeneration: lessons from alpha-synuclein. Exp. Gerontol. (2006)
4. Barrachina M., Castano E., Dalfo E., Maes T., Buesa C., and Ferrer I. Reduced ubiquitin C-terminal hydrolase-1 expression levels in dementia with Lewy bodies. Neurobiol. Dis. 22 (2006) 265-273
5. Bennett M.C., Bishop J.F., Leng Y., Chock P.B., Chase T.N., and Mouradian M.M. Degradation of alpha-synuclein by proteasome. J. Biol. Chem. 274 (1999) 33855-33858
6. Berger Z., Ravikumar B., Menzies F.M., Oroz L.G., Underwood B.R., Pangalos M.N., Schmitt I., Wullner U., Evert B.O., O'Kane C.J., and Rubinsztein D.C. Rapamycin alleviates toxicity of different aggregate-prone proteins. Hum. Mol. Genet. 15 (2006) 433-442
7. Cantuti-Castelvetri I., Klucken J., Ingelsson M., Ramasamy K., McLean P.J., Frosch M.P., Hyman B.T., and Standaert D.G. Alpha-synuclein and chaperones in dementia with Lewy bodies. J. Neuropathol. Exp. Neurol. 64 (2005) 1058-1066
8. Cao S., Gelwix C.C., Caldwell K.A., and Caldwell G.A. Torsin-mediated protection from cellular stress in the dopaminergic neurons of Caenorhabditis elegans. J. Neurosci. 25 (2005) 3801-3812
9. Cataldo A.M., Hamilton D.J., and Nixon R.A. Lysosomal abnormalities in degenerating neurons link neuronal compromise to senile plaque development in Alzheimer disease. Brain Res. 640 (1994) 68-80
10. Cooper A.A., Gitler A.D., Cashikar A., Haynes C.M., Hill K.J., Bhullar B., Liu K., Xu K., Strathearn K.E., Liu F., Cao S., Caldwell K.A., Caldwell G.A., Marsischky G., Kolodner R.D., Labaer J., Rochet J.C., Bonini N.M., and Lindquist S. Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science 313 (2006) 324-328
11. Cuervo A.M., and Dice J.F. Unique properties of lamp2a compared to other lamp2 isoforms. J. Cell Sci. 113 Pt 24 (2000) 4441-4450
12. Cuervo A.M., Stefanis L., Fredenburg R., Lansbury P.T., and Sulzer D. Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 305 (2004) 1292-1295
13. Dauer W., Kholodilov N., Vila M., Trillat A.C., Goodchild R., Larsen K.E., Staal R., Tieu K., Schmitz Y., Yuan C.A., Rocha M., Jackson-Lewis V., Hersch S., Sulzer D., Przedborski S., Burke R., and Hen R. Resistance of alpha -synuclein null mice to the parkinsonian neurotoxin MPTP. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 14524-14529
14. Dean R.T. Lysosomes and protein degradation. Ciba Found. Symp. (1979) 139-149
15. Ding W.X., Ni H.M., Gao W., Yoshimori T., Stolz D.B., Ron D., and Yin X.M. Linking of autophagy to ubiquitin-proteasome system is important for the regulation of endoplasmic reticulum stress and cell viability. Am. J. Pathol. 171 (2007) 513-524
16. Ding W.X., and Yin X.M. Sorting, recognition and activation of the misfolded protein degradation pathways through macroautophagy and the proteasome. Autophagy 4 (2008) 141-150
17. Drolet R.E., Behrouz B., Lookingland K.J., and Goudreau J.L. Mice lacking alpha-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration. Neurotoxicology 25 (2004) 761-769
18. Fujita E., Kouroku Y., Isoai A., Kumagai H., Misutani A., Matsuda C., Hayashi Y.K., and Momoi T. Two endoplasmic reticulum-associated degradation (ERAD) systems for the novel variant of the mutant dysferlin: ubiquitin/proteasome ERAD(I) and autophagy/lysosome ERAD(II). Hum. Mol. Genet. 16 (2007) 618-629
19. Gao H.M., Kotzbauer P.T., Uryu K., Leight S., Trojanowski J.Q., and Lee V.M. Neuroinflammation and oxidation/nitration of alpha-synuclein linked to dopaminergic neurodegeneration. J. Neurosci. 28 (2008) 7687-7698
20. Giasson B.I., Duda J.E., Quinn S.M., Zhang B., Trojanowski J.Q., and Lee V.M. Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein. Neuron 34 (2002) 521-533
21. Hara T., Nakamura K., Matsui M., Yamamoto A., Nakahara Y., Suzuki-Migishima R., Yokoyama M., Mishima K., Saito I., Okano H., and Mizushima N. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441 (2006) 885-889
22. Hayashita-Kinoh H., Yamada M., Yokota T., Mizuno Y., and Mochizuki H. Down-regulation of alpha-synuclein expression can rescue dopaminergic cells from cell death in the substantia nigra of Parkinson's disease rat model. Biochem. Biophys. Res. Commun. 341 (2006) 1088-1095
23. Hunter J.M., Lesort M., and Johnson G.V. Ubiquitin-proteasome system alterations in a striatal cell model of Huntington's disease. J. Neurosci. Res. 85 (2007) 1774-1788
24. Ii K., Ito H., Tanaka K., and Hirano A. Immunocytochemical co-localization of the proteasome in ubiquitinated structures in neurodegenerative diseases and the elderly. J. Neuropathol. Exp. Neurol. 56 (1997) 125-131
25. Kahle P.J. Alpha-synucleinopathy models and human neuropathology: similarities and differences. Acta Neuropathol. 115 (2008) 87-95
26. Keller J.N., Gee J., and Ding Q. The proteasome in brain aging. Ageing Res. Rev. 1 (2002) 279-293
27. Kiffin R., Kaushik S., Zeng M., Bandyopadhyay U., Zhang C., Massey A.C., Martinez-Vicente M., and Cuervo A.M. Altered dynamics of the lysosomal receptor for chaperone-mediated autophagy with age. J. Cell Sci. 120 (2007) 782-791
28. Klivenyi P., Siwek D., Gardian G., Yang L., Starkov A., Cleren C., Ferrante R.J., Kowall N.W., Abeliovich A., and Beal M.F. Mice lacking alpha-synuclein are resistant to mitochondrial toxins. Neurobiol. Dis. 21 (2006) 541-548
29. Komatsu M., Waguri S., Chiba T., Murata S., Iwata J.I., Tanida I., Ueno T., Koike M., Uchiyama Y., Kominami E., and Tanaka K. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441 (2006) 880-884
30. Komatsu M., Waguri S., Koike M., Sou Y.S., Ueno T., Hara T., Mizushima N., Iwata J.I., Ezaki J., Murata S., Hamazaki J., Nishito Y., Iemura S.I., Natsume T., Yanagawa T., Uwayama J., Warabi E., Yoshida H., Ishii T., Kobayashi A., Yamamoto M., Yue Z., Uchiyama Y., Kominami E., and Tanaka K. Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell 131 (2007) 1149-1163
31. Lee H.J., Khoshaghideh F., Patel S., and Lee S.J. Clearance of alpha-synuclein oligomeric intermediates via the lysosomal degradation pathway. J. Neurosci. 24 (2004) 1888-1896
32. Lee V.M., and Trojanowski J.Q. Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery. Neuron 52 (2006) 33-38
33. Leverenz J.B., Umar I., Wang Q., Montine T.J., McMillan P.J., Tsuang D.W., Jin J., Pan C., Shin J., Zhu D., and Zhang J. Proteomic identification of novel proteins in cortical lewy bodies. Brain Pathol. 17 (2007) 139-145
34. Li W., Lesuisse C., Xu Y., Troncoso J.C., Price D.L., and Lee M.K. Stabilization of alpha-synuclein protein with aging and familial parkinson's disease-linked A53T mutation. J. Neurosci. 24 (2004) 7400-7409
35. Martin L.J., Pan Y., Price A.C., Sterling W., Copeland N.G., Jenkins N.A., Price D.L., and Lee M.K. Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death. J. Neurosci. 26 (2006) 41-50
36. Martinez-Vicente M., Talloczy Z., Kaushik S., Massey A.C., Mazzulli J., Mosharov E.V., Hodara R., Fredenburg R., Wu D.C., Follenzi A., Dauer W., Przedborski S., Ischiropoulos H., Lansbury P.T., Sulzer D., and Cuervo A.M. Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy. J. Clin. Invest. (2008)
37. Masliah E., Rockenstein E., Veinbergs I., Mallory M., Hashimoto M., Takeda A., Sagara Y., Sisk A., and Mucke L. Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science 287 (2000) 1265-1269
38. Massey A.C., Kaushik S., Sovak G., Kiffin R., and Cuervo A.M. Consequences of the selective blockage of chaperone-mediated autophagy. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 5805-5810
39. Massey A.C., Zhang C., and Cuervo A.M. Chaperone-mediated autophagy in aging and disease. Curr. Top. Dev. Biol. 73 (2006) 205-235
40. McLean P.J., Kawamata H., and Hyman B.T. Alpha-synuclein-enhanced green fluorescent protein fusion proteins form proteasome sensitive inclusions in primary neurons. Neuroscience 104 (2001) 901-912
41. McNaught K.S., Belizaire R., Isacson O., Jenner P., and Olanow C.W. Altered proteasomal function in sporadic Parkinson's disease. Exp. Neurol. 179 (2003) 38-46
42. McNaught K.S., Bjorklund L.M., Belizaire R., Isacson O., Jenner P., and Olanow C.W. Proteasome inhibition causes nigral degeneration with inclusion bodies in rats. Neuroreport 13 (2002) 1437-1441
43. McNaught K.S., and Jenner P. Proteasomal function is impaired in substantia nigra in Parkinson's disease. Neurosci. Lett. 297 (2001) 191-194
44. McNaught K.S., Shashidharan P., Perl D.P., Jenner P., and Olanow C.W. Aggresome-related biogenesis of Lewy bodies. Eur. J. Neurosci. 16 (2002) 2136-2148
45. Meredith G.E., Totterdell S., Petroske E., Santa C.K., Callison Jr. R.C., and Lau Y.S. Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson's disease. Brain Res. 956 (2002) 156-165
46. Nakamura Y., Takeda M., Suzuki H., Morita H., Tada K., Hariguchi S., and Nishimura T. Lysosome instability in aged rat brain. Neurosci. Lett. 97 (1989) 215-220
47. Nixon R.A., Wegiel J., Kumar A., Yu W.H., Peterhoff C., Cataldo A., and Cuervo A.M. Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. J. Neuropathol. Exp. Neurol. 64 (2005) 113-122
48. Nuber S., Petrasch-Parwez E., Winner B., Winkler J., von H.S., Schmidt T., Boy J., Kuhn M., Nguyen H.P., Teismann P., Schulz J.B., Neumann M., Pichler B.J., Reischl G., Holzmann C., Schmitt I., Bornemann A., Kuhn W., Zimmermann F., Servadio A., and Riess O. Neurodegeneration and motor dysfunction in a conditional model of Parkinson's disease. J. Neurosci. 28 (2008) 2471-2484
49. Pandey U.B., Nie Z., Batlevi Y., McCray B.A., Ritson G.P., Nedelsky N.B., Schwartz S.L., DiProspero N.A., Knight M.A., Schuldiner O., Padmanabhan R., Hild M., Berry D.L., Garza D., Hubbert C.C., Yao T.P., Baehrecke E.H., and Taylor J.P. HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature 447 (2007) 859-863
50. Qiao L., Hamamichi S., Caldwell K.A., Caldwell G.A., Yacoubian T.A., Wilson S., Xie Z.L., Speake L.D., Parks R., Crabtree D., Liang Q., Crimmins S., Schneider L., Uchiyama Y., Iwatsubo T., Zhou Y., Peng L., Lu Y., Standaert D.G., Walls K.C., Shacka J.J., Roth K.A., and Zhang J. Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity. Mol. Brain 1 (2008) 17
51. Rideout H.J., Lang-Rollin I., and Stefanis L. Involvement of macroautophagy in the dissolution of neuronal inclusions. Int. J. Biochem. Cell Biol. 36 (2004) 2551-2562
52. Rideout H.J., and Stefanis L. Proteasomal inhibition-induced inclusion formation and death in cortical neurons require transcription and ubiquitination. Mol. Cell. Neurosci. 21 (2002) 223-238
53. Robertson D.C., Schmidt O., Ninkina N., Jones P.A., Sharkey J., and Buchman V.L. Developmental loss and resistance to MPTP toxicity of dopaminergic neurones in substantia nigra pars compacta of gamma-synuclein, alpha-synuclein and double alpha/gamma-synuclein null mutant mice. J. Neurochem. 89 (2004) 1126-1136
54. Sampathu D.M., Giasson B.I., Pawlyk A.C., Trojanowski J.Q., and Lee V.M. Ubiquitination of alpha-synuclein is not required for formation of pathological inclusions in alpha-synucleinopathies. Am. J. Pathol. 163 (2003) 91-100
55. Sarkar S., Davies J.E., Huang Z., Tunnacliffe A., and Rubinsztein D.C. Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein. J. Biol. Chem. 282 (2007) 5641-5652
56. Sarkar S., Krishna G., Imarisio S., Saiki S., O'Kane C.J., and Rubinsztein D.C. A rational mechanism for combination treatment of Huntington's disease using lithium and rapamycin. Hum. Mol. Genet. 17 (2008) 170-178
57. Sarkar S., and Rubinsztein D.C. Inositol and IP3 levels regulate autophagy: biology and therapeutic speculations. Autophagy 2 (2006) 132-134
58. Sevlever D., Jiang P., and Yen S.H. Cathepsin D is the main lysosomal enzyme involved in the degradation of alpha-synuclein and generation of its carboxy-terminally truncated species. Biochemistry (2008)
59. Shin Y., Klucken J., Patterson C., Hyman B.T., and McLean P.J. The co-chaperone carboxyl terminus of Hsp70-interacting protein (CHIP) mediates alpha-synuclein degradation decisions between proteasomal and lysosomal pathways. J. Biol. Chem. 280 (2005) 23727-23734
60. Singleton A.B., Farrer M., Johnson J., Singleton A., Hague S., Kachergus J., Hulihan M., Peuralinna T., Dutra A., Nussbaum R., Lincoln S., Crawley A., Hanson M., Maraganore D., Adler C., Cookson M.R., Muenter M., Baptista M., Miller D., Blancato J., Hardy J., and Gwinn-Hardy K. Alpha-synuclein locus triplication causes Parkinson's disease. Science 302 (2003) 841
61. Tofaris G.K., Layfield R., and Spillantini M.G. Alpha-synuclein metabolism and aggregation is linked to ubiquitin-independent degradation by the proteasome. FEBS Lett. 509 (2001) 22-26
62. Vernace V.A., Schmidt-Glenewinkel T., and Figueiredo-Pereira M.E. Aging and regulated protein degradation: who has the UPPer hand?. Aging Cell (2007)
63. Webb J.L., Ravikumar B., Atkins J., Skepper J.N., and Rubinsztein D.C. Alpha-synuclein is degraded by both autophagy and the proteasome. J. Biol. Chem. 278 (2003) 25009-25013
64. Williams A., Sarkar S., Cuddon P., Ttofi E.K., Saiki S., Siddiqi F.H., Jahreiss L., Fleming A., Pask D., Goldsmith P., O'Kane C.J., Floto R.A., and Rubinsztein D.C. Novel targets for Huntington's disease in an mTOR-independent autophagy pathway. Nat. Chem. Biol. 4 (2008) 295-305
65. Willingham S., Outeiro T.F., DeVit M.J., Lindquist S.L., and Muchowski P.J. Yeast genes that enhance the toxicity of a mutant huntingtin fragment or alpha-synuclein. Science 302 (2003) 1769-1772
66. Yu W.H., Cuervo A.M., Kumar A., Peterhoff C.M., Schmidt S.D., Lee J.H., Mohan P.S., Mercken M., Farmery M.R., Tjernberg L.O., Jiang Y., Duff K., Uchiyama Y., Naslund J., Mathews P.M., Cataldo A.M., and Nixon R.A. Macroautophagy-a novel Beta-amyloid peptide-generating pathway activated in Alzheimer's disease. J. Cell Biol. 171 (2005) 87-98